Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Media
  • News
  • Penny Stocks

Rite Aid Starts Selling Abortion Medication From Few Pharmacies: Report

By Vandana Singh
Today, 3:04 AM
Rite Aid Corp (NYSE: RAD) plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery.

CVS

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

FDA Rejects Eli Lilly’s Donanemab For Alzheimer’s Disease, Needs More Data

By Vandana Singh
Today, 3:04 AM
The FDA issued a complete response letter for the accelerated approval submission of Eli Lilly And Co’s (NYSE:LLY) donanemab for early symptomatic…

BIIB

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Guidance
  • Large Cap
  • News
  • Price Target

What To Expect When General Dynamics Reports Fourth Quarter Results Next Week

By Vandana Singh
Today, 3:04 AM
Credit Suisse expected General Dynamics Corp (NYSE: GD) to report fourth-quarter FY22 slightly ahead, with upside potential driven by G650 delivery strength and repurchases, when the aerospace and defense giant reports its earnings next week on Jan. 25.

GD

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Price Target
  • Reiteration

Analyst Views Novo Nordisk’s Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly’s Tirzepatide

By Vandana Singh
Today, 3:04 AM
Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023. 

AMGN

Read More
2 minute read
  • Financing
  • General
  • Large Cap
  • Media
  • News
  • Social Media
  • Top Stories

Morgan Stanley’s Role In Musk’s Twitter Acquisition: Advisers, Not Owners

By AJ Fabino
Today, 3:04 AM
Morgan Stanley (NYSE: MS) CEO James Gorman laid to rest any investor uncertainty Thursday as it pertains to the investment bank’s position, or potential ownership, of Elon Musk’s micro-blogging platform T

MS

Read More
4 minute read
  • Cryptocurrency
  • Earnings
  • General
  • Large Cap
  • Legal
  • Markets
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Another Crypto Firm Collapses, Microsoft Slashes Workforce, Fake Cannabis Billionaire Pleads Guilty: Top Stories For Thursday, Jan. 19

By Vandana Singh
Today, 3:04 AM
Bloomberg

C

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Genentech’s Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer

By Vandana Singh
Today, 3:04 AM
Genentech, a unit of Roche Holdings AG (OTC:RHHBY), announced that the Phase 3 IMbrave050 study met its primary endpoint of recurrence-free survival…

RHHBF

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Johnson & Johnson’s HIV Vaccine Regimen Does Not Prevent Infection, Phase 3 Study Shows

By Vandana Singh
Today, 3:04 AM
 The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) announced the results of an independent, scheduled data review of the Phase 3 Mosaico study of the investigational HIV vaccine regimen. 

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • News
  • Tech

Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm

By Vandana Singh
Today, 3:04 AM
Bayer AG (OTC:BAYRY) (OTC:BAYZF) has agreed to acquire Blackford Analysis Ltd, a British developer of artificial intelligence (AI) systems offering clinical…

BAYRY

Read More
2 minute read
  • Large Cap
  • News
  • Tech
  • Top Stories

Another Tech Giant Prepares For Major Layoffs, This Time 11,000 Jobs Will Be Cut: Report

By Michael Cohen
Today, 3:04 AM
Tech giant Microsoft Inc (NASDAQ: MSFT) is preparing to lay off thousands of employees, according to multiple reports.

AMZN

Posts navigation

Previous 1 … 16 17 18 … 107 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service